More about an “Exercise Pill”
July 4, 2017 | Terry Sharrer
In our June 27 issue you saw a story about an exercise pill under research at Augusta University in Georgia. The piece here reports similar studies at the Salk Institute, where scientists found a compound, “GW1516” (apparently a modification of a drug GW501516 which GlaxoSmithKline worked on during the 1990s) that suppresses sugar metabolism in muscles in favor of fat burning (in laboratory mice). In effect, this mimicked the effects of exercise. However, it’s worth remembering that GSK abandoned its compound because it was carcinogenic. MORE WITH VIDEO
Image Credit: commons.wikimedia.org